| [1] |
Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation:the basis of graft acceptance[J]. Hepatology, 1993, 17(6):1127-1152. doi: 10.1002/(ISSN)1527-3350
|
| [2] |
Devlin J, Doherty D, Thomson L, et al. Defining the outcome of immunosuppression withdrawal after liver transplantation[J]. Hepatology, 1998, 27(4):926-933. doi: 10.1002/(ISSN)1527-3350
|
| [3] |
Feng S, Ekong UD, Lobritto SJ, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants[J]. JAMA, 2012, 307(3):283-293. DOI: 10.1001/jama.2011.2014.
|
| [4] |
Benítez C, Londoño MC, Miquel R, et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients[J]. Hepatology, 2013, 58(5):1824-1835. DOI: 10.1002/hep.26426.
|
| [5] |
Bohne F, Martínez-Llordella M, Lozano JJ, et al. Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation[J]. J Clin Invest, 2012, 122(1):368-382. DOI 10.1172/JCI59411. doi: 10.1172/JCI59411
|
| [6] |
Calne RY. Prope tolerance:a step in the search for tolerance in the clinic[J]. World J Surg, 2000, 24(7):793-796. doi: 10.1007/s002680010127
|
| [7] |
Donckier V, Craciun L, Miqueu P, et al. Expansion of memory-type CD8+ T cells correlates with the failure of early immunosuppression withdrawal after cadaver liver transplantation using high-dose ATG induction and rapamycin[J]. Transplantation, 2013, 96(3):306-315. DOI: 10.1097/TP.0b013e3182985414.
|
| [8] |
Benítez CE, Puig-Pey I, López M, et al. ATG-Fresenius treatment and low-dose tacrolimus:results of a randomized controlled trial in liver transplantation[J]. Am J Transplant, 2010, 10(10):2296-2304. DOI: 10.1111/j.1600-6143.2010.03164.x.
|
| [9] |
Donckier V, Craciun L, Lucidi V, et al. Acute liver transplant rejection upon immunosuppression withdrawal in a tolerance induction trial:potential role of IFN-gamma-secreting CD8+ T cells[J]. Transplantation, 2009, 87(9 Suppl):S91-S95. DOI: 10.1097/TP.0b013e3181a2dee6.
|
| [10] |
Tan J, Wu W, Xu X, et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants:a randomized controlled trial[J]. JAMA, 2012, 307(11):1169-1177. DOI: 10.1001/jama.2012.316.
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: